Abstract
Previously, we have shown, in golden Syrian hamsters, that chronic feeding of ursodeoxycholic acid (UDCA), in contrast to that of its 7α-epimer, chenodeoxycholic acid (CDCA), produced a significant increment in hepatic low-density lipoprotein (LDL) uptake, despite similar suppression of bile acid synthesis by both bile acids. Evidence for a direct effect of this bile acid on hepatic LDL metabolism was shownin vitro, with isolated hamster hepatocytes, suggesting that this effect was unique to UDCA and specific for receptor-mediated LDL catabolism. The aim of the present study was to define the cellular mechanism(s) associated with this phenomenon, using male golden Syrian hamsters. Regardless of chronic exposure of the liver to either UDCA or CDCA, acute incubation with UDCA consistently resulted in an increase of LDL binding to isolated hepatocytes by 15 to 40%. Furthermore, chronic treatment with either UDCA or CDCA did not result in alterations in lipoprotein particle composition. Likewise, incubation of hepatocytes with UDCA was not associated with a change of the membrane lipid composition. In isolated liver membrane fractions, UDCA increased both the maximum number of LDL binding sites and the affinity constant for LDL by around 35% suggesting an interaction of UDCA with the LDL receptor, at the plasma membrane level, independent of an effect on receptor cycling. The results of the studies support a role for UDCA in the recruitment of cryptic LDL receptors from a cellular membrane pool, possibly due to the unique localization of UDCA in the plasma membrane lipid bilayer.
Similar content being viewed by others
Abbreviations
- CDCA:
-
chenodeoxycholic acid
- FC:
-
free cholesterol
- GUDCA:
-
glycine conjugate of UDCA
- HDL:
-
high-density lipoprotein
- IDL:
-
intermediate-density lipoprotein
- LDL:
-
low-density lipoprotein
- PAGE:
-
polyacrylamide gel electrophoresis
- PC:
-
phosphatidylcholine
- PL:
-
phospholipid
- TG:
-
triglyceride
- TUDCA:
-
taurine conjugate of UDCA
- UDCA:
-
ursodeoxycholic acid
- VLDL:
-
very low density lipoprotein
References
Brown, M.S., and Goldstein, J.L. (1986) A Receptor-Mediated Pathway for Cholesterol Homeostasis,Science 232, 34–47.
Vega, G.L., and Grundy, S.M. (1987) Mechanism of Primary Hypercholesterolemia in Humans,Am. Heart J. 113, 493–502.
Mahley, R.W., Hui, D.Y., and Innerarity, T.L. (1981) Two Independent Lipoprotein Receptors on Hepatic Membranes of Dog, Swine, and Man,J. Clin. Invest. 68, 1197–1206.
Turley, S.D., and Dietschy, J.M. (1988) The Metabolism and Excretion of Cholesterol by the Liver, inThe Liver: Biology and Pathology (Arias, I.M., Jakoby, W.B., Popper, H., Schachter, D., and Shafritz, D.A., eds.) pp. 617–641, Raven Press, New York.
Spady, D.K., Turley, S.D., and Dietschy, J.M. (1985) Rates of Low Density Lipoprotein Uptake and Cholesterol Synthesis Are Regulated Independently in the Liver,J. Lipid Res. 26, 465–472.
Goldstein, J.L., and Brown, M.S. (1976) The LDL Pathway in Human Fibroblasts: A Receptor-Mediated Mechanism for the Regulation of Cholesterol Metabolism,Curr. Top. Cell Regul. 11, 147–181.
Goldstein, J.L., and Brown, M.S. (1977) The Low-Density Lipoprotein Pathway and Its Relation to Atherosclerosis,Ann. Rev. Biochem. 46, 897–930.
Brown, M.S., and Goldstein, J.L. (1983) Lipoprotein Receptors in the Liver,J. Clin. Invest. 72, 743–747.
Brown, M.S., Dana, S.E., and Goldstein, J.L. (1975) Receptor-Dependent Hydrolysis of Cholesteryl Esters Contained in Plasma Low Density Lipoprotein,Proc. Natl. Acad. Sci. U.S.A. 72, 2925–2929.
Brown, M.S., Kovanen, P.T., and Goldstein, J.L. (1979) Receptor-Mediated Uptake of Lipoprotein-Cholesterol and Its Utilization for Steroid Synthesis in the Adrenal Cortex,Recent Prog. Horm. Res. 35, 215–257.
Spady, D.K., and Dietschy, J.M. (1985) Dietary Saturated Triacylglycerols Suppress Hepatic Low Density Lipoprotein Receptor Activity in the Hamster,Proc. Natl. Acad. Sci. U.S.A. 82, 4526–4530.
Davidson, N.O., Kollmer, M.E., and Glickman, R.M. (1986) Apolipoprotein B Synthesis in Rat Small Intestine: Regulation by Dietary Triglyceride and Biliary Lipid,J. Lipid Res. 27, 30–39.
Woollett, L.A., D.K. Spady, and Dietschy, J.M. (1992) Saturated and Unsaturated Fatty Acids Independently Regulate Low Density Lipoprotein Receptor Activity and Production Rate,J. Lipid Res. 33, 77–88.
Woollett, L.A., Spady, D.K., and Dietschy, J.M. (1992) Regulatory Effects of the Saturated Fatty Acids 6∶0 Through 18∶0 on Hepatic Low Density Lipoprotein Receptor Activity in the Hamster,J. Clin. Invest. 89, 1133–1141.
Ma, P.T.S., Gil, G., Sudhof, T.C., Bilheimer, D.W., Goldstein, J.L., and Brown, M.S. (1986) Mevinolin, an Inhibitor of Cholesterol Synthesis, Induces mRNA for Low Density Lipoprotein Receptor in Livers of Hamsters and Rabbits,Proc. Natl. Acad. Sci. U.S.A. 83, 8370–8373.
Hoeg, J.M., Maher, M.B., Zech, L.A., Bailey, K.R., Gregg, R.E., Lackner, K.J., Fojo, S.S., Anchors, M.A., Bojanovski, M., Sprecher, D.L., and Brewer, Jr., H.B. (1986) Effectiveness of Mevinolin on Plasma Lipoprotein Concentrations in Type II Hyperlipoproteinemia,Am. J. Cardiol. 57, 933–939.
Kempen, H.J., Van Son, K., Cohen, L.H., Griffioen, M., Verboom, H., and Havekes, L. (1987) Effect of Ketoconazole on Cholesterol Synthesis and on HMG-CoA Reductase and LDL-Receptor Activities in HepG2 Cells,Biochem. Pharmacol. 36, 1245–1249.
Gupta, A.K., Sexton, R.C., and Rudney, H. (1990) Differential Regulation of Low Density Lipoprotein Suppression of HMG-CoA Reductase Activity in Cultured Cells by Inhibitors of Cholesterol Biosynthesis,J. Lipid Res. 31, 203–215.
Kovanen, P.T., Bilheimer, D.W., Goldstein, J.L., Jaramillo, J.J., and Brown, M.S. (1981) Regulatory Role for Hepatic Low Density Lipoprotein Receptorsin Vivo in the Dog,Proc. Natl. Acad. Sci. U.S.A. 78, 1994–1998.
Kume, N., Kita, T., Mikami, A., Yokode, M., Ishii, K., Nagano, Y., and Kawai, C. (1989) Induction of mRNA for Low-Density Lipoprotein Receptors in Heterozygous Watanabe Heritable Hyperlipidemic Rabbits Treated with CS-514 (Pravastatin) and Cholesteramine,Circulation 79, 1084–1090.
Bihain, B.E., Deckelbaum, R.J., Yen, F.T., Gleeson, A.M., Carpenter, Y.A., and Witte, L.D. (1989) Unesterified Fatty Acids Inhibit the Binding of Low Density Lipoproteins to the Human Fibroblast Low Density Lipoprotein Receptor,J. Biol. Chem. 264, 17316–17321.
Kuo, P., Weinfeld, M., and Loscalzo, J. (1990) Effect of Membrane Fatty Acyl Composition on LDL Metabolism in Hep G2 Hepatocytes,Biochemistry 29, 6626–6632.
Rudling, M., and Angelin, B. (1993) Stimulation of Rat Hepatic Low Density Lipoprotein Receptors by Glucagon. Evidence of a Novel Regulatory Mechanism in Vivo,J. Clin. Invest. 91, 2796–2805.
Chappell, D.A., Fry, G.L., Waknitz, M.A., and Berns, J.J. (1991) Ligand Size as a Determinant for Catabolism by the Low Density Lipoprotein (LDL) Receptor Pathway. A Lattice Model for LDL Binding,J. Biol. Chem. 266, 19296–19302.
McKeone, B.J., Patsch, J.R., and Pownall, H.J. (1993) Plasma Triglycerides Determine Low Density Lipoprotein Composition, Physical Properties, and Cell-Specific Binding in Cultured Cells,J. Clin. Invest. 91, 1926–1933.
Malavolti, M., Fromm, H., Ceryak, S., and Roberts I.M. (1987) Modulation of Low Density Lipoprotein Receptor Activity by Bile Acids: Differential Effects of Chenodeoxycholic and Ursodeoxycholic Acids in the Hamster,J. Lipid. Res. 28, 1281–1295.
Bouscarel, B., Fromm, H., Ceryak, S., and Cassidy, M.M. (1991) Ursodeoxycholic Acid Increases Low-Density Lipoprotein Binding, Uptake and Degradation in Isolated Hamster Hepatocytes,Biochem. J. 280, 589–598.
Exton, J.H. (1975) The Perfused Rat Liver,Methods Enzymol. 37, 23–40.
Redgrave, T.G., Roberts, D.C.K., and West, C.E. (1975) Separation of Plasma Lipoproteins by Density-Gradient Ultracentrifugation,Anal. Biochem. 65, 42–49.
Bradford, M.M. (1976) A Rapid and Sensitive Method for the Quantitation of Microgram Quantities Utilizing the Principle of Protein-Dye Binding,Anal. Biochem. 98, 231–237.
Irwin, D., O'Looney, P.A., Quinet, E., and Vahouny, G.V. (1984) Application of SDS Gradient Polyacrylamide Slab Gel Electrophoresis to Analysis of Apolipoprotein Mass and Radioactivity of Rat Lipoproteins,Atherosclerosis 53, 163–172.
Switzer, R.C., Merril, C.R., and Shifrin, S. (1979) A Highly Sensitive Silver Stain for Detecting Proteins and Peptides in Polyacrylamide Gels,Anal. Biochem. 98, 231–237.
Elvitch, F.R., Aronson, S.B., Feichtmeir, T.V., and Enterline, M.L. (1966) Thin Gel Electrophoresis in Agarose,Am. J. Clin. Path. 46, 692–697.
Papadopoulos, N.M., and Kintzios, J.A. (1969) Determination of Human Serum Lipoproteins by Agarose Gel Electrophoresis,Anal. Biochem. 30, 421–426.
Fromm, H., Carlson, G.L., Hofmann, A.F., Farivar, S., and Amin, P. (1980) Metabolism in Man of 7-Ketolithocholic Acid: Precursor of Cheno- and Ursodeoxycholic Acids,Am. J. Physiol., G161–G166.
McFarlane, A.S. (1958) Efficient Trace-Labelling of Proteins with Iodine,Nature (London) 182, 53.
Bilheimer, D.W., Eisenberg, S., and Levy, R.I. (1972) The Metabolism of Very Low Density Lipoprotein Proteins. I. Preliminaryin Vivo andin Vitro Observations,Biochim. Biophys. Acta 260, 212–221.
Bouscarel, B., Fromm, H., and Nussbaum, R. (1993) Ursodeoxycholate Mobilizes Intracellular Ca2+ and Activates Phosphorylase a in Isolated Hepatocytes,Am. J. Physiol. 264, G243-G251.
Prpic, V., Green, K.C., Blackmore, P.F., and Exton, J.H. (1984) Vasopressin-, Angiotensin II-, and α1-Adrenergic-Induced Inhibition of Ca2+ Transport by Rat Liver Plasma Membrane Vesicles,J. Biol. Chem. 259, 1382–1385.
Kovanen, P.T., Brown, M.S., and Goldstein, J.L. (1979) Increased Binding of Low Density Lipoprotein to Liver Membranes from Rats Treated with 17α-Ethinyl Estradiol,J. Biol. Chem. 254, 11367–11373.
Scatchard, G. (1949) The Attraction of Proteins for Small Molecules and Ions,Ann. NY. Acad. Sci. 51, 660–672.
McPherson, G.A. (1985)Kinetic, EBDA, Ligand, Lowry. A Collection of Radioligand Binding Analysis Programs, pp. 14–96, Elsevier Science Publishers BV, Amsterdam.
Bligh, E.G., and Dyer, W.J. (1959) A Rapid Method of Total Lipid Extraction and Purification,Can. J. Biochem. Physiol. 37, 911–917.
Patton, G.M., Fasulo, J.M., and Robins, S.J. (1990) Analysis of Lipids by High-Performance Liquid Chromatography: Part I,J. Nutr. Biochem. 1, 493–500.
Patton, G.M., Fasulo, J.M., and Robins, S.J. (1990) Analysis of Lipids by High-Performance Liquid Chromatography. Part II: Phospholipids,J. Nutr. Biochem. 1, 549–556.
Bartlett, G.R. (1959) Phosphorus Assay in Column Chromatography,J. Biol. Chem. 234, 466–468.
Singhal, A.K., Finver-Sadowsky, J., McSherry, C., and Mosbach, E.H. (1983) Effect of Cholesterol and Bile Acids on the Regulation of Cholesterol Metabolism in the Hamster,Biochim. Biophys. Acta 752, 214–222.
Fromm, H., Roat, J.W., Gonzalez, V., Sarva, R.P., and Farivar, S. (1983) Comparative Efficacy and Side Effects of Ursodeoxycholic and Chenodeoxycholic Acids in Dissolving Gallstones,Gastroenterology 85, 1257–1264.
Leiss, O., Von Bergmann, K., Streicher, U., and Strotkoetter, H. (1984) Effect of Three Different Dihydroxy Bile Acids on Intestinal Cholesterol Absorption in Normal Volunteers,Gastroenterology 87, 144–149.
Nielsell K.B., Angelin, B., Leijd, B., and Einarsson, K. (1983) Comparative Effects of Ursodeoxycholic Acid and Chenodeoxycholic Acid on Bile Acid Kinetics and Biliary Lipid Secretion in Humans,Gastroenterology 85, 1248–1256.
Angelin, B., Raviola, C.A., Innerarity, T.L., and Mahley, R.W. (1983) Regulation of Hepatic Lipoprotein Receptors in the Dog. Rapid Regulation of Apolipoprotein B,E. Receptors, But Not of Apolipoprotein E Receptors, by Intestinal Lipoproteins and Bile Acids,J. Clin. Invest. 71, 816–831.
Duckworth, P.F., Vlahcevic, Z.R., Studer, E.J., Gurley, E.C., Heuman, D.M., Beg, Z.H., and Hylemon, P.B. (1991) Effect of Hydrophobic Bile Acids on 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Activity and mRNA Levels in the Rat,J. Biol. Chem. 266, 9413–9418.
Shefer, S., Nguyen, L.B., Salen, G., Ness, G.C., Chowdhary, I.R., Lerner, S., Batta, A.K., and Tint, G.S. (1992) Differing Effects of Cholesterol and Taurocholate on Seady-State Hepatic HMG-CoA Reductase and Cholesterol 7α-Hydroxylase Activities and mRNA Levels in the Rat,J. Lipid Res. 33, 1193–1200.
Güldütuna, S., Zimmer, G., Imhof, M., Bhatti, S., You, T., and Leuschner, U. (1993) Molecular Aspects of Membrane Stabilization by Ursodeoxycholate,Gastroenterology 104, 1736–1744.
Leuschner, U., Fischer, H., Kurtz, W., Güldütuna, S., Hübner, K., Hellstern, A., Gatzen, M., and Leuschner, M. (1989) Ursodeoxycholic Acid in Primary Biliary Cirrhosis: Results of a Controlled Double Blind Trial,Gastroenterology 97, 1268–1274.
Galle, P.R., Theilmann, L., Raedsch, R., Otto, G., and Stiehl, A. (1990) Ursodeoxycholate Reduces Hepatoxicity of Bile Salts in Primary Human Hepatocytes,Hepatology 12, 486–491.
Havel, R.J. (1986) Role of the Liver in Lipoprotein Catabolism,Methods Enzymol. 129, 591–612.
Quig, D.W., Arbeeny, C.M., and Zilversmit, D.B. (1991) Effect of Hyperlipidemias in Hamsters on Lipid Transfer Protein Activity and Unidirectional Cholesteryl Ester Transfer in Plasma,Biochim. Biophys. Acta 1083, 257–264.
Triggle, D.J. (1982) Receptor Recruitment and Cryptic Signals,Trends Pharmacol. Sci. 3, 273–274.
Author information
Authors and Affiliations
About this article
Cite this article
Bouscarel, B., Caryak, S., Robins, S.J. et al. Studies on the mechanism of the ursodeoxycholic acid-induced increase in hepatic low-density lipoprotein binding. Lipids 30, 607–617 (1995). https://doi.org/10.1007/BF02536997
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02536997